Visiopharm and Proscia® Partner to Deliver AI-Enabled Solutions that Advance Precision Medicine

March 10th, 2020 - HOERSHOLM and PHILADELPHIA 

Collaboration unifies image analysis and image management in a single solution for realizing the full promise of computational pathology data

Visiopharm, the leader in precision pathology software, and Proscia, a leader in digital pathology image and workflow management, have entered into a multi-year, strategic partnership to deliver deeply integrated AI-enabled solutions that drive breakthroughs in translational research and advance precision medicine. In addition to joint product integration, Visiopharm and Proscia have established a global reseller and support agreement to accelerate the delivery of these combined offerings to the market.

Read more

Agilent and Visiopharm Co-promote Advanced Digital Precision Pathology Solutions

March 2nd, 2020 - SANTA CLARA, California; and COPENHAGEN, Denmark

Enabling better cancer diagnostics via artificial intelligence-driven solutions

Agilent Technologies Inc. (NYSE: A) and Visiopharm today announced that they have entered a long-term collaboration agreement. The announcement is happening at the USCAP 109th Annual Meeting being held on February 29 through March 5, 2020, in Los Angeles, CA.

Read more

Visiopharm Announces Long Term Exclusive Contract With Marylou Tyler

January 5th, 2020

Visiopharm, the leader in AI-driven digital precision pathology and Marylou Tyler, industry leader in sales process improvement and bestselling author announce that they are entering into a long-term exclusive collaboration to implement a scalable, growth-driven sales development program.

With a history of optimizing the sales process and implementing predictable new sales opportunity engines, Marylou brings over 30 years of experience in developing effective and sustainable sales process strategies for clients such as MasterCard, Apple,, and Talend.

Read more

UK Government Invests in Visiopharm, Increasing Access to Ground-Breaking Digital Pathology in the NHS

December 2nd, 2019

The Danish-based leader in augmented pathology solutions Visiopharm has secured a grant worth £250,000 from UK Research and Innovation to test its innovative solutions in partnership with the NHS.

The grant, offered by the UK Government’s innovations fund, was offered specifically to boost SMEs offering support to evaluate an innovative medical technology.

Read more